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INTRODUCTION
¨Primary Sjogren’s syndrome (SS) is an autoimmune
disorder characterized by lymphocytic infiltrates
and destruction of the salivary and lacrimal glands,
and systemic production of autoantibodies to the
ribonucleoprotein (RNP) particles SS-A/Ro and SS-B/
La (1-4). The spectrum of presentation of the dis-
ease is broad, ranging from the organ-localized dys-
function of exocrine gland to systemic complications
such as liver, kidney and lung involvement (5).
Although it has been assumed that a combination
of immunologic, genetic, and environmental factors
may play a key role on the development of autoimmune
lesions, little is known about the disease pathogenesis.
Autoimmune diseases are characterized by tissue
destruction and functional decline due to autoreactive
T cells that escape self-tolerance (6, 7). Although
the specificity of cytotoxic T lympyocyte (CTL) func-
tion has been an important issue of organ-specific
autoimmune response, the mechanisms respon-
sible for tissue destruction in SS remain to be elu-
cidated. The histopathological changes in the mi-
nor salivary gland biopsy are characterized by fo-
cal and/or diffuse lymphoid cell infiltrates and
parenchymal destruction. The majority of lymph-
oid cells in the salivary biopsy are CD4+ T cells with
a small proportion of CD8+ T cells (2). These T cells
express the αβ antigen receptor and cell surface
antigens associated with mature memory T cells.
Since it was evident a preferential use of specific
variable region segments of the antigen receptor β
chain by salivary gland T cells (8), it has been as-
sumed that a unknown organ-specific autoantigen
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targeted by autoreactive T cells may be present in
the salivary glands. We have established and ana-
lyzed an animal model for primary SS in NFS/sld
mutant mice thymectomized 3 day after birth (3d-TX)
(9-20). When the repertoire of T cell receptor (TCR)
Vβ genes transcribed and expressed within the in-
flammatory infiltrates was analyzed in an animal
model, a preferential utilization of TCR Vβ gene
was detected in these lesions from the onset of
disease (10). We have previously identified a 120
kDa organ-specific autoantigen from the salivary
gland tissues of this animal model (21). The sequence
of the first 20 NH2-terminal residues was found to
be identical to that of cytoskeletal protein human
α-fodrin (21). Furthermore, sera from patients with
SS reacted positively with purified 120 kDa anti-
gen, and proliferative response of peripheral blood
lymphocytes (PBMC) from SS patients to the purified
autoantigen was detected, but not from SLE or RA
patients, and healthy controls. These results indi-
cate that the anti-120 kDa α-fodrin immune response
plays an essential role on the development of pri-
mary SS. Recent reports have demonstrated evidences
that caspase 3 is required for α-fodrin cleavage dur-
ing apoptosis (22-24). In Jurkat cells, caspase 3-like
proteases have been reported to cleave α-fodrin
and poly (ADP-ribose) polymerase (PARP) but with
differential sensitivity to the caspase 3 inhibitor,
DEVD-CHO (24). We speculate that an increase in
the enzymatic activity of apoptotic proteases is in-
volved in the progression of α-fodrin proteolysis
during development of SS.
Involvement of Fas and FasL in tissue de-
struction
It is now clear that the interaction of Fas with
FasL regulates a large number of pathophysiological
process of apoptosis (25, 26). We speculate that an
increase in the enzymatic activity of apoptotic proteases
is involved in the progression of α-fodrin proteolysis
during development of SS. To determine the possible
involvement of Fas and FasL in tissue destruction
of SS, we first analyzed Fas expression in the sali-
vary gland specimens of 3d-thymectomized (3d-Tx)
NFS/sld mouse model (10) and in the mouse salivary
gland cells (MSG) isolated from non-thymectomized
(non-Tx) NFS/sld mice. Immunohistology revealed
that the majority of tissue-infiltrating lymphoid cells
in the salivary glands bear FasL in SS model, and
epithelial duct cells express Fas antigen on their
cell surface. We found that tissue-infiltrating CD4+
T cells isolated from the affected glands bear a large
proportion of FasL (>85%), compared with CD8+ T
cells bearing FasL on flow cytometry (<23%)(P<
0.01)(Fig. 1A). A minor proportion of infiltrating
CD4+ T cells express Fas (<31%), and CD8+ T cells
bearing Fas were negligible (<5%). Primarily cul-
tured MSG cells isolated from 3d-Tx, non-Tx NFS/sld
and C57BL/6 mice constitutively express Fas with
high proportion (51%-60%) on flow cytometry (Fig.
1B). Immunohistochemically, epithelial duct cells
in non-Tx NFS/sld and C57BL/6 salivary glands
are positive for Fas. RT-PCR analysis demonstrated
that Fas mRNA was constitutively present in the
salivary glands of SS model, non-Tx NFS/sld , and
normal C57BL/6 mice. MSG cells isolated from these
mice did not express FasL on flow cytometric analy-
sis. A significant increase of TUNEL+-apoptotic epi-
thelial duct cells in the salivary glands was observed
in SS model mice, compared with those in non-Tx
NFS/sld, and C57BL/6 mice at all ages. We next
investigated whether tissue-infiltrating T cells are
responsible for tissue destruction as judged by
in vitro 51Cr release cytotoxic assay against MSG
cells. Infiltrating CD4+ T cells, but not CD8+ T cells,
identified significant 51Cr release against MSG cells.
These cytotoxic activities were almost entirely in-
hibited by incubation with anti-murine neutralizing
FasL mAb (FLIM58 : 1µg/ml), indicating that the
cytotoxicity by activated CD4+ T cells towards sali-
vary gland epithelial cells was Fas-based.
Participation of caspases in α-fodrin cleav-
age
To confirm the organ-specificity of a cleavage
product of α-fodrin, we investigated various strains
of mice with salivary gland destruction, such as
MRL/lpr, nonobese diabetic (NOD) mice, in addi-
tion to 3d-TX NFS/sld mice. Protein immunoblot
analysis demonstrated that the 120 kDa α-fodrin was
detected in these affected glands, but not in normal
mice. We examined the in vitro cleavage of α-fodrin
using 240 KDa α-fodrin in MSG cells. Anti-Fas
Ab-induced apoptosis was confirmed by FACS analy-
sis using in situ TUNEL procedure, and DNA laddering
and formation. We could detect the 120 kDa α-fodrin
in apoptotic MSG cells on immunoblotting. We ex-
amined the in vitro cleavage of α-fodrin in MSG cells
induced by anti-Fas mAb (Jo2 : 300 ngml-1). Anti-Fas
mAb-stimulated apoptosis in MSG cells was con-
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firmed by flow cytometry of DNA content of nuclei
with PI and Annexin V. Western blot analysis
demonstrated that the 240 kDa α-fodrin in apoptotic
MSG cells was cleaved to smaller fragments into
120 kDa on time-dependent manner, and the cleav-
age was entirely blocked by preincubation with
caspase inhibitors (z-VAD-fmk, DEVD-CHO)(Fig.
2A). Protease inhibitor cocktails, cysteine protease in-
hibitors (E 64), and serine protease inhibitor (Leupeptin)
had no significant effect on 120 kDa α-fodrin cleav-
age in apoptotic MSG cells (Fig. 2A). The 113 kDa
PARP in apoptotic MSG cells was not cleaved to
smaller fragments. We next investigated whether
cysteine proteases are involved in α-fodrin cleav-
age on apoptotic MSG cells. The caspase 1- and
caspase 3-like activities in anti-Fas mAb-stimulated
MSG cell extracts were determined using fluorescent
substrates (27), and caspase inhibitors (z-VAD-fmk,
DEVD-CHO) inhibited these activities at different
dose (0.2, 2, and 20 µM) (Fig. 2B).
Preventive effect of caspase inhibitors in vivo
We next examined whether α-fodrin cleavage to
120 kDa fragment on apoptotic human salivary gland
cells (HSG)(28) could be blocked by preincubation
with specific protease inhibitors. In apoptotic HSG
cells, calpain inhibitor peptide and caspase inhibitor
(Z-VAD-fmk) had partially blocked 120 kDa α-fodrin
formation. Moreover, a combination of calpain in-
hibitor peptide and caspase inhibitors (Z-VAD-fmk
and Z-DEVD-fmk) almost entirely inhibited the for-
mation of 120 kDa α-fodrin. Protease inhibitor cock-
tails, other cysteine protease inhibitors (E64), and
serine protease inhibitor (Leupeptin) had no effect
on 120 kDa α-fodrin cleavage in apoptotic HSG cells.
By immunohistochemistry using polyclonal Ab
against synthetic 120 kDa α-fodrin, a cleavage prod-
uct of α-fodrin was present exclusively in epithelial
duct cells of the labial salivary gland biopsies from
SS patients, but not in control individuals. Protein
Figure 1. FasL and Fas expression in the salivary gland tissues from 3d-Tx NFS/sld mice. (A) Flow cytometric analysis of FasL
expression on tissue-infiltrating lymphocytes isolated from salivary glands of 3d-Tx NFS/sld mice gated on CD4, and CD8. FasL
expression on tissue-infiltrating CD4+ T cells was prominent compared with that on CD8+ T cells. Five mice in each group were
analyzed at 8-, and 12-wk-old of age. (B) Flow cytometric analysis of Fas expression on MSG cells from 3d-Tx, non-Tx NFS/sld , and
normal C57BL/6 mice. Fas expression was constitutively observed on MSG cells from each group of mice. Five mice in each group
were analyzed.
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immunoblot analysis confirmed the same results.
This indicates that a cleavage product of 120 kDa
α-fodrin is present in the diseased glands with hu-
man SS, but not in control glands. We further inves-
tigated whether the i.v. injection of caspase-inhibitors
protects SS animal model against the development
of autoimmune lesions. The both treatment with i.
v. injection of z-VAD-fmk and DEVD-CHO (3 times
per week) (P<0.005) prevented the development of
autoimmune lesions in the salivary and lacrimal
glands. The average saliva and tear volume of the
treated SS animal model was significantly higher
than that of the control group. A significant de-
crease of autoantigen-specific T cell proliferation
was observed in spleen cells from treated mice. In
addition, serum autoantibody production against
Figure 2. (A) Western blot analysis demonstrated that the 240 kDa α-fodrin in apoptotic MSG cells was cleaved to smaller frag-
ments into 120 kDa on time-dependent manner, and the cleavage product was entirely blocked by preincubation with caspase
inhibitors (z-VAD-fmk, DEVD-CHO) measured at 24 h. Protease inhibitor cocktails, cysteine protease inhibitors (E64), and serine
protease inhibitor (Leupeptin) had no significant effect on α-fodrin cleavage. (B) Activation of caspase 1-like and caspase 3-like
proteases was detected during anti-Fas-induced apoptosis, and caspase inhibitors inhibited these activities. Cytosolic extracts were
prepared from MSG cells (1×107 cells) which were treated at 37℃ with 300 ngml-1 of Jo-2. 100% activity as control was calculated
using the values that 300U/ml recombinant caspase 1 or caspase 3 was added to each substrate (200 µM MOCAc-YVAD(dnp)-NH2
and MOCAc-DEVD (dnp)-NH2).
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120 kDa α-fodrin was clearly inhibited by the treat-
ment with caspase-inhibitors. The treatment of
murine SS model with i.v. injection of z-VAD-fmk
and DEVD-CHO prevented the development of
autoimmune conditions, resulting in restoration of
saliva and tear secretion. These results suggest that
increased activity of caspase cascade is involved in
the progression of α-fodrin proteolysis during the
initial stages on the development of primary SS.
Autoimmune lesions induced by immuniza-
tion with autoantigen
To examine the autoimmune nature of 120 kDa
α-fodrin, recombinant α-fodrin protein identical to
an autoantigen was administerred subcutaneously
(s.c.) into normal NFS/sld mice at 4 wks. Organ-specific
autoimmune lesions similar to SS developed at 8
wks after the injection in almost all mice immunized
with autoantigen, but not in all groups of control (19).
No inflammatory lesions were observed in other
organs. A majority of infiltrating cells were CD4+
and FasL+, and the epithelial duct cells express Fas
on their cell surface. A specific cleavage of α-fodrin
into 120 kDa was detected in the salivary glands of
immunized mice, but not in controls. Mice injected
with recombinant autoantigen showed a significant
increase of autoantigen-specific T cell proliferation
in spleen cells. A high titer of serum autoantibodies
against 120 kDa α-fodrin was detected in immunized
mice, compared with control mice by ELISA. These
data demonstrated evidences that a cleavage prod-
uct of 120 kDa α-fodrin is pathogenic autoantigen
on the development of murine primary SS.
Concluding remarks
There is increasing evidences that the cascade
of caspases is a critical component of the cell death
pathway (29-31), and a few proteins have been found
to be cleaved during apoptosis. We provided evidence
that α-fodrin is cleaved by one or more members
of caspases during apoptotic cell death in SS sali-
vary glands. Fodrin cleavage by caspases can po-
tentially lead to cytoskeltal rearrangement, and it
is of interest to point out that α-fodrin binds to
ankylin, which contains a cell death domain (32).
It has been shown that cleavage products of α-fodrin
inhibit ATP-dependent glutamate and γ-aminobutyric
acid accumulation into synaptic vesicles (33), suppos-
ing that a cleavage product of 120 kDa α-fodrin could
be a novel component of an unknown immunoregulatory
networks such as cytolinker proteins (34). These
results are strongly suggestive of essential roles of
caspase cascade for α-fodrin cleavage leading to
tissue destruction in autoimmune exocrinopathy
of primary SS.
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